Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now later-stage tilt small index

Coronary Stenosis: later-stage trial registry

2 of 6 indexed Coronary Stenosis trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Coronary Stenosis: 6 US clinical trials tracked, 2 recruiting.

Coronary Stenosis is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, running 1 of these trials.

Enrollment posture brief

Registry condition coronary-stenosis

OPEN 2 | RECR 33% | LATE 1 | EARLY 0 | RANK #2866 | SPON 1

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Coronary Stenosis (this)33%
Open-enrollment share among volume-matched conditions near Coronary Stenosis

Coronary Stenosis lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Coronary Stenosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Coronary Stenosis is recruiting below its size-band peers.

    2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Coronary Stenosis research.

    Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Coronary Stenosis enrolment sits around 1,085 participants.

    Median target enrolment is 1,085 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.

  4. Coronary Stenosis research is mostly interventional.

    5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Named interventions

Most-linked intervention names on Coronary Stenosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Resolute Onyx Stent Device
1 trials
Resolute Integrity Stent Device
1 trials
FFR guided PCI Procedure
1 trials
Aged garlic extract and Coenzyme Q10 Dietary supplement
1 trials
Coronary artery stenting: Absorb BVS Device
1 trials
Comprehensive therapy program for risk factor modification Other
1 trials
CABG Procedure
1 trials
Percutaneous Coronary Intervention (PCI) Procedure
1 trials

US sites by state

Facility locations filed on Coronary Stenosis trials. A trial with sites in several states counts in each.

California 4 trials
Massachusetts 3 trials
Georgia 3 trials
Texas 2 trials
Minnesota 2 trials
Kansas 2 trials
Illinois 2 trials
Florida 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Coronary Stenosis page

6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Coronary Stenosis condition card totals 6 registered trials; most-linked intervention Resolute Onyx Stent; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.